Development of serum models that can predict clinical outcomes in chronic liver disease

开发可预测慢性肝病临床结果的血清模型

• 批准号: nhmrc : 1128889
• 负责人: A/Pr Leon Adams
• 金额: $ 25.96万
• 依托单位: The University of Western Australia
• 依托单位国家: 澳大利亚
• 项目类别: Project Grants
• 财政年份: 2017
• 资助国家: 澳大利亚
• 起止时间: 2017-01-01 至 2019-12-31
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/development-serum-models-liver-disease/948292
• 关键词: Development; serum; models; predict; clinical

The overall objective of this project is to develop blood tests that can accurately predict liver related death, liver cancer and liver decompensation respectively for patients with chronic liver disease. Blood tests will also be developed to predict cardiovascular disease in patients with non-alcoholic fatty liver disease. Furthermore, we will evaluate the use of repeated blood tests to assess if this can more accurately predict death and complications compared to a single time point.

该项目的总体目标是开发出能够准确预测慢性肝病患者肝脏相关死亡、肝癌和肝脏失代偿的血液检测方法。血液测试也将被开发来预测非酒精性脂肪性肝病患者的心血管疾病。此外，我们将评估重复验血的使用，以评估与单一时间点相比，这是否可以更准确地预测死亡和并发症。